Behandling mot ulcerös kolit får EU-godkännande

Abbvies behandling Skyrizi har fått tummen upp för ytterligare en indikation i EU. Behandlingen godkänns nu för behandling av ulcerös kolit.

”Det viktiga är att man skapar en överblick och förståelse från olika perspektiv”

Forskaren Jochen Schwenk analyserar blodproteiner med hjälp av proteomik för att förbättra vår förståelse av sjukdom och hälsa. Han modererar i år eventet Lab &...

Confidence in childhood vaccines is in decline worldwide

Since the pandemic, confidence in vaccinating children has plummeted. In a new report, UNICEF urges world leaders to act before the situation worsens. In 52 out...

Ovanlig genetisk sjukdom behandlad i livmodern för första gången

Ett barn har för första gången behandlats mot spinal muskelatrofi redan i magen på sin mamma. Barnet, som nu är två och ett halvt år gammalt, visar inga symptom...

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Affibody AB

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Nanoparticles to help detect pulmonary disease

Nanoparticles behave in a certain way in the air. Using this knowledge, researchers at Lund University have developed a new measurement method for lung examinat...

New diagnostic rules raise concerns

In a panel discussion, several voices from academia and the industry expressed concerns about the transition to the new regulatory framework for in-vitro diagno...

AI speeds up measurement process

How to inspect coatings ten times faster with a light microscope? The medical technology group Smith+Nephew has been using ZEISS Axio Imager.Z2m since summer 2022.

RegSmart Life Science AB

The Swedish National Board of Health and Welfare rejects prioritising andrology as a speciality

Male infertility can be linked to a shorter lifespan and several severe diseases, but when couples who want children are examined, the focus is on the woman. Ex...

Truly Labs AB

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

Exploring Molecular Dynamics with Raster Image Correlation Spectroscopy

Understand how RICS can be used to measure diffusion coefficients.

Jättestudie: Fördelarna med fetmaläkemedel – och riskerna

Läkemedel som Ozempic kan minska risken för en rad olika sjukdomar och hälsotillstånd, men också öka risken för andra komplikationer. Det enligt en stor amerika...

MedVasc and Scientific Solutions join forces to streamline FDA 510(k) regulatory process

MedVasc, an exciting MedTech startup company, and Scientific Solutions, a renowned consulting firm within Life Science, are pleased to announce a strategic part...

Happy International Women's Day!

This March, we're dedicating Fridays to spotlight women in STEM. The first article is about Helena, a Sales Engineer in Sweden. Read why she likes to work with ...

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Rapid developments in AI – “All stakeholders are struggling to understand it”

Artificial intelligence is being discussed more and more, and developments in the field are moving rapidly. As the Swedish Medical Products Agency testifies, ke...

Faster development of reliable sample handling

Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...

Lundbeck behind the first EU-approved intravenous migraine treatment

A preventive, intravenous treatment for migraines has been approved in the EU for the first time.

RegFile AB

Donanemab godkänns i Storbritannien – men anses för dyrt för skattebetalarna

Eli Lillys alzheimerläkemedel donanemab godkänns i Storbritannien – men lär ändå inte bli tillgängligt för vanliga patienter. Orsaken är att behandlingen bedöms...